首页> 外文期刊>Translational research: the journal of laboratory and clinical medicine >Proteomic analysis of fine-needle aspiration in differential diagnosis of thyroid nodules
【24h】

Proteomic analysis of fine-needle aspiration in differential diagnosis of thyroid nodules

机译:甲状腺结节鉴别诊断中细针展出的蛋白质组学分析

获取原文
获取原文并翻译 | 示例
           

摘要

Thyroid nodules are common in the general population and vary widely in their propensity to harbor thyroid malignancies. The category of follicular lesion of undetermined significance, for instance, carries only a 15% risk of malignancy. The overarching aim of this work was the proteomic study of thyroid cancer because more effort needs to be placed on differentiating malignant thyroid nodules to avoid unnecessary thyroidectomy. We used 2-dimensional electrophoresis coupled to nano-liquid chromatography electrospray ionization tandem mass spectrometry, to examine fine-needle aspiration (FNA), which was easily attainable from the wash of the syringe used for classical FNA biopsy. Overall, we found 25 different proteins able to discriminate benign from malignant samples. The different expression of moesin; annexin A1 (ANXA1); cornulin (CRNN); lactate dehydrogenase; enolase; protein DJ-1; and superoxide dismutase was confirmed in FNA by enzyme-linked immunosorbent assay or Western blot. Receiver operating characteristic curves were calculated to investigate the discriminative power of our marker. The best performance in diagnosis was obtained by combining ANXA1, enolase, protein DJ-1, superoxide dismutase, and CRNN. In addition, the most highly ranked proteins, from the perspective of follicular lesion of undetermined significance, were ANXA1 and CRNN. The research of these candidate biomarkers has then been widened to other biological fluids, such as serum and whole saliva. In conclusion, we believe that when a decision by a thyroid nodule biopsy cannot be distinctly made, the combination of our biomarkers may be one of the criteria to be taken into account for the final decision, together with the identification of ANXA1 in serum and saliva.
机译:甲状腺结节在一般人群中很常见,并以其对含甲状腺恶性恶性肿瘤的倾向而广泛变化。例如,卵泡病变的卵泡病变的类别仅携带15%的恶性肿瘤风险。这项工作的总体旨视是甲状腺癌的蛋白质组学研究,因为需要更加努力,以差异化恶性甲状腺结节以避免不必要的甲状腺切除术。我们使用二维电泳耦合到纳米液相色谱电离电离串联质谱法,以检查细针抽吸(FNA),从用于经典FNA活组织检查的注射器的洗涤易于达到的细针抽吸(FNA)。总的来说,我们发现了25种不同的蛋白质能够区分恶性样本。 moesin的不同表达; Annexin A1(ANXA1); Cornulin(CRNN);乳酸脱氢酶; enolase;蛋白质DJ-1;通过酶联免疫吸附测定或蛋白质印迹在FNA中证实超氧化物歧化酶。计算接收器操作特征曲线以研究我们标记的辨别力。通过组合ANXA1,ENOLASE,蛋白DJ-1,超氧化物歧化酶和CRNN来获得最佳诊断性能。此外,来自滤泡性损伤的角度,最高排名最高的蛋白质,均为ANXA1和CRNN。这些候选生物标志物的研究随后被扩大到其他生物液体,例如血清和整个唾液。总之,我们认为,当甲状腺结节活检的决定不能清楚地制定时,我们的生物标志物的组合可以是最终决定考虑的标准之一,以及血清和唾液中的ANXA1的鉴定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号